Bold Health’s IBS Self-Management App Zemedy Demonstrates Efficacy In Clinical Trial

Bold Health, a digital health company providing integrative virtual care and digital therapies for gastrointestinal conditions (GI) announced the results from their randomized controlled trial (RCT) in collaboration with the University of Pennsylvania, on the efficacy of Zemedy, a mobile digital therapeutic for irritable bowel syndrome (IBS). People using Zemedy reported significant improvements in IBS symptoms, quality of life, and mental health scores compared to the waitlist control group.

Zemedy consists of six modules focusing on psychoeducation, relaxation training, exercise and nutritional information. Its cognitive model of stress management applies CBT to IBS symptoms, reducing avoidance through exposure therapy and . . .